@amcunningham personally think the pharma side of things needs a lot more investigation too. fear kelsey's 'transparancy' is 1-way mirror
-
-
Replying to @carolinejmolloy
@carolinejmolloy it's a given that CPRD data is sold to pharma. Has been for years. People seem more surprised about insurers.1 reply 0 retweets 0 likes -
Replying to @amcunningham
@amcunningham@carolinejmolloy that's handy for pharma, no? Disinformation3 replies 0 retweets 0 likes -
Replying to @MossLorraine
@MossLorraine@carolinejmolloy but no one seems interested in discussing CPRD. It's seen as a 'good thing'. Also has opt-out model.1 reply 0 retweets 0 likes -
-
Replying to @carolinejmolloy
@carolinejmolloy@MossLorraine Basically I start from the position that research is a 'good thing' too. But I'd like to be discuss it!1 reply 0 retweets 0 likes -
Replying to @amcunningham
.
@amcunningham@carolinejmolloy@MossLorraine Research can be good - IF it's published. Nobody should get data w/o 100% publish rate, imho.3 replies 1 retweet 1 like -
Replying to @C7RKY
@C7RKY@amcunningham@carolinejmolloy@MossLorraine Pharma data should be mergerd INTO the#NHS database & NHS should do the analysis.1 reply 1 retweet 0 likes -
Replying to @atm0spheric
@atm0spheric there's an argument that NHS should do all analysis on NHS data@C7RKY@carolinejmolloy@MossLorraine4 replies 4 retweets 2 likes -
Replying to @amcunningham
@amcunningham@C7RKY@carolinejmolloy@MossLorraine IMHO it's a compellingly strong argument - hopefully gaining weight.1 reply 0 retweets 0 likes
.@atm0spheric @amcunningham @carolinejmolloy @MossLorraine It's a better one. But let's not forget, NHSEng have questions to answer here too
-
-
Replying to @C7RKY
@C7RKY@amcunningham@carolinejmolloy@MossLorraine Good point - ..... AND we need to fix the#NHS1 reply 1 retweet 0 likes - 1 more reply
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.